Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
0.452
-0.001 (-0.26%)
Nov 20, 2024, 4:00 PM EST - Market closed
HSDT Revenue
Helius Medical Technologies had revenue of $51.00K in the quarter ending September 30, 2024, a decrease of -64.34%. This brings the company's revenue in the last twelve months to $502.00K, down -36.62% year-over-year. In the year 2023, Helius Medical Technologies had annual revenue of $644.00K, down -18.17%.
Revenue (ttm)
$502.00K
Revenue Growth
-36.62%
P/S Ratio
1.76
Revenue / Employee
$22,818
Employees
22
Market Cap
1.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 644.00K | -143.00K | -18.17% |
| Dec 31, 2022 | 787.00K | 265.00K | 50.77% |
| Dec 31, 2021 | 522.00K | -139.00K | -21.03% |
| Dec 31, 2020 | 661.00K | -835.00K | -55.82% |
| Dec 31, 2019 | 1.50M | 1.02M | 212.97% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| cbdMD | 20.64M |
| iCoreConnect | 11.05M |
| SCWorx | 3.22M |
| China SXT Pharmaceuticals | 1.93M |
| Tivic Health Systems | 957.00K |
| 60 Degrees Pharmaceuticals | 462.61K |
HSDT News
- 3 days ago - Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device - GlobeNewsWire
- 5 weeks ago - Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece - GlobeNewsWire
- 3 months ago - Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 3 months ago - Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024 - GlobeNewsWire
- 5 months ago - Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke - GlobeNewsWire
- 6 months ago - Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference - Accesswire